Relmada Therapeutics Inc logo

Relmada Therapeutics Inc

STU:4E2 (USA)  
€ 2.76 (+1.47%) May 24
At Loss
P/B:
1.28
Market Cap:
€ 85.12M ($ 92.39M)
Enterprise V:
€ 7.79M ($ 8.45M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:

Relmada Therapeutics Inc Operating Data

Relmada Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

Relmada Therapeutics Inc (STU:4E2) Operating Data Charts